Clinical Trial Update: A Titration Trial to Determine the Effectiveness of Testosterone MD-Lotion (Cutaneous Solution) Formulations [Phase 3]

View source ↗

Summary

A Phase 3 titration trial assessing the effectiveness of Testosterone MD-Lotion (cutaneous solution) for hypogonadism has completed, with results posted in 2011…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism

Drugs mentioned

• Testosterone MD-Lotion (cutaneous solution) (testosterone)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Hypogonadism | Phase 3 | Status: COMPLETED | Results posted: 2011-01-05